Lately prescription for repeat are being filled as it has huge effect and health improvement in high blood
pressure patients. Insurances are covering it. Soon prescriptions will be doubled.
C'mon q1 earnngs will reflect launch and 2 months of initial sales. Its bound to be a big loss. But thats not news, its all about continued progress.
Sentiment: Strong Buy
when is it??
BUT... Cash burn for SG&A will expose a very weak cash position. The next step will be dilution to raise $$$ to continue the sales efforts and FDA trials. I am LONG 6500 shares now, but this is going to be a bumpy ride....
Well stock price is saying expectations are pretty low, so I think a significant beat and positive guidance
is going to propel this much higher over the next month into earnings / QC
AMRN 1st quarter $2m 2nd quarter $11m 3rd based on 11% increase $42m 4th $178m Total 2013 $233m